Get the Stockscreener App
204.87
1.50%
-3.11
Pre-market:
204.95
0.08
+0.04%
Natera Inc stock is traded at $204.87, with a volume of 808.77K.
It is down -1.50% in the last 24 hours and up +3.40% over the past month.
Natera Inc is a diagnostic and research company with proprietary molecular and bioinformatics technology. The company's key product offerings include its Panorama Non-Invasive Prenatal Test (NIPT) which screens for chromosomal abnormalities of a fetus as well as in twin pregnancies, typically with a blood draw from the mother, Horizon Carrier Screening (HCS) to determine carrier status for a large number of severe genetic diseases that could be passed on to the carrier's children, Signatera molecular residual disease (MRD) test, which detects circulating tumor DNA in patients previously diagnosed with cancer to assess molecular residual disease and monitor for recurrence; and Prospera, to assess organ transplant rejection.
See More
Previous Close:
$207.98
Open:
$206.34
24h Volume:
808.77K
Relative Volume:
0.69
Market Cap:
$29.04B
Revenue:
$2.31B
Net Income/Loss:
$-208.16M
P/E Ratio:
-133.33
EPS:
-1.5366
Net Cash Flow:
$76.11M
1W Performance:
+9.65%
1M Performance:
+3.40%
6M Performance:
+20.24%
1Y Performance:
+53.04%
1-Day Range:
$203.14
$208.32
1-Week Range:
$190.29
$210.99
52-Week Range:
$125.38
$256.36
Natera Inc Stock (NTRA) Company Profile
Name
Natera Inc
Sector
Industry
Phone
650-249-9090
Address
13011 MCCALLEN PASS, AUSTIN, CA
Compare NTRA vs TMO, DHR, IDXX, A, WAT
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
NTRA
Natera Inc
|
204.87 | 29.04B | 2.31B | -208.16M | 76.11M | -1.5366 |
TMO
Thermo Fisher Scientific Inc
|
488.19 | 181.35B | 44.56B | 6.72B | 6.29B | 17.74 |
DHR
Danaher Corp
|
192.12 | 135.96B | 24.57B | 3.60B | 5.26B | 5.051 |
IDXX
Idexx Laboratories Inc
|
577.44 | 45.86B | 4.30B | 1.06B | 1.04B | 13.08 |
A
Agilent Technologies Inc
|
114.84 | 32.45B | 7.07B | 1.29B | 993.00M | 4.5355 |
WAT
Waters Corp
|
304.09 | 29.83B | 3.17B | 642.63M | 516.49M | 10.77 |
Natera Inc Stock (NTRA) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Jan-07-26 | Initiated | Citigroup | Buy |
| Dec-02-25 | Resumed | Morgan Stanley | Overweight |
| Oct-27-25 | Upgrade | BNP Paribas Exane | Underperform → Neutral |
| Sep-22-25 | Resumed | Wells Fargo | Equal Weight |
| Mar-13-25 | Initiated | RBC Capital Mkts | Outperform |
| Jan-23-25 | Initiated | Barclays | Overweight |
| Jun-03-24 | Resumed | Jefferies | Buy |
| Apr-08-24 | Resumed | Craig Hallum | Buy |
| Feb-20-24 | Downgrade | Raymond James | Strong Buy → Outperform |
| Dec-29-23 | Reiterated | BTIG Research | Buy |
| Dec-14-23 | Initiated | Guggenheim | Buy |
| Dec-13-23 | Initiated | Wolfe Research | Outperform |
| Nov-13-23 | Upgrade | Raymond James | Outperform → Strong Buy |
| Sep-28-23 | Initiated | Bernstein | Mkt Perform |
| Jul-05-23 | Resumed | JP Morgan | Overweight |
| May-05-23 | Initiated | UBS | Buy |
| Jan-18-23 | Upgrade | Raymond James | Mkt Perform → Outperform |
| Aug-25-22 | Initiated | Credit Suisse | Outperform |
| Apr-25-22 | Initiated | Stephens | Overweight |
| Mar-08-22 | Initiated | Goldman | Buy |
| Jan-06-22 | Resumed | Piper Sandler | Overweight |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Jun-15-21 | Initiated | Raymond James | Mkt Perform |
| May-25-21 | Initiated | Wells Fargo | Overweight |
| Jan-28-21 | Initiated | Truist | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Sep-28-20 | Initiated | Morgan Stanley | Overweight |
| Sep-17-20 | Initiated | SVB Leerink | Outperform |
| Jun-10-20 | Resumed | Piper Sandler | Overweight |
| May-07-20 | Upgrade | JP Morgan | Neutral → Overweight |
| Oct-05-18 | Initiated | JP Morgan | Neutral |
| Jul-05-18 | Reiterated | Piper Jaffray | Overweight |
| Aug-07-17 | Reiterated | Morgan Stanley | Overweight |
| Nov-10-16 | Reiterated | The Benchmark Company | Buy |
| May-23-16 | Reiterated | The Benchmark Company | Buy |
| May-11-16 | Reiterated | The Benchmark Company | Buy |
| Apr-19-16 | Initiated | The Benchmark Company | Buy |
| Sep-28-15 | Upgrade | Wedbush | Neutral → Outperform |
| Aug-14-15 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Aug-04-15 | Initiated | Robert W. Baird | Outperform |
| Jul-27-15 | Initiated | Morgan Stanley | Equal-Weight |
| Jul-27-15 | Initiated | Piper Jaffray | Overweight |
| Jul-27-15 | Initiated | Wedbush | Neutral |
View All
Natera Inc Stock (NTRA) Latest News
Judge Slashes Damages For Natera In Invitae Patent Case - Law360
Natera, Inc. (NTRA) Stock Price, News, Quote & History - Yahoo! Finance Canada
Assessing Natera (NTRA) Valuation After New Signatera Breast Cancer Study Results - simplywall.st
Insider Sell Alert: Daniel Rabinowitz Sells 8,400 Shares of Nate - GuruFocus
Natera (NASDAQ:NTRA) Downgraded to Hold Rating by Wall Street Zen - MarketBeat
Natera (NASDAQ:NTRA) Insider Solomon Moshkevich Sells 3,000 Shares of Stock - marketbeat.com
Natera SEC. sold $1.7m in NTRA stock By Investing.com - Investing.com Australia
Natera president sells $606,899 in NTRA stock - Investing.com
Natera SEC. sold $1.7m in NTRA stock - Investing.com
Natera (NTRA) president sells 3,000 shares under Rule 10b5-1 plan - Stock Titan
Natera president sells $606,899 in NTRA stock By Investing.com - Investing.com India
Natera, Inc. (NTRA) stock price, news, quote and history - Yahoo Finance Australia
Insiders At Natera Sold US$40m In Stock, Alluding To Potential Weakness - 富途牛牛
Natera's Signatera data suggests select breast cancer patients could skip surgery - MSN
Natera sec. and chief legal officer sells $307k in stock - Investing.com
Natera at Raymond James Conference: Strategic Growth and Innovation - Investing.com
Natera, Inc. $NTRA Shares Sold by SWS Partners - MarketBeat
Natera, Inc. Files Form 8-K Reporting Company Details and Regulatory Compliance as of March 26, 2026 - Minichart
Natera (NTRA) chair exercises 41,708 options, now holds 2.35M shares - Stock Titan
Natera Jumps After Exceeding Earnings Expectations and Unprecedented Institutional Purchases Even as Insiders Sell - bitget.com
Natera Expands Board, Appoints Eric Rubin as Director - TipRanks
Natera appoints Eric Rubin to board, expands board size to eleven members By Investing.com - Investing.com Canada
Natera appoints Eric Rubin to board, expands board size to eleven members - Investing.com
Eric Rubin appointed to Natera board as Class I director - TradingView
Natera, Inc. Appoints Eric Rubin to the Board and Member of Nominating, Corporate Governance and Compliance Committee, Effective March 26, 2026 - marketscreener.com
Eric Rubin joins Natera (NASDAQ: NTRA) board as independent director - Stock Titan
Solomon Moshkevich files Form 144; 3,000 Performance Shares (NTRA) - Stock Titan
Exploring 3 High Growth Tech Stocks In The US Market - simplywall.st
J. Safra Sarasin Holding AG Makes New Investment in Natera, Inc. $NTRA - MarketBeat
Signatera Data in Older Breast Cancer Patients Could Be A Game Changer For Natera (NTRA) - simplywall.st
Natera, Inc. $NTRA Shares Sold by Allspring Global Investments Holdings LLC - MarketBeat
Natera's Signatera Data Suggests Select Breast Cancer Patients Could Skip Surgery - Benzinga
Avoiding Lag: Real-Time Signals in (NTRA) Movement - Stock Traders Daily
Natera, Inc. $NTRA Shares Sold by Zevenbergen Capital Investments LLC - MarketBeat
Why Natera Stock Is Surging Despite Recent Volatility - TipRanks
Blood test helped some women over 70 with breast cancer avoid surgery - Stock Titan
SG Americas Securities LLC Reduces Stock Holdings in Natera, Inc. $NTRA - MarketBeat
Natera reports outcomes from study of MRD test for soft tissue and bone sarcomas - MSN
Natera Inc (NTRA) Shares Down 6.88% on Mar 30 - GuruFocus
Is It Time To Reassess Natera (NTRA) After Recent Share Price Pullback - Yahoo Finance
Prenatal Testing Market Is Booming Rapidly with Strong Demand - openPR.com
Dakota Wealth Management Buys Shares of 5,921 Natera, Inc. $NTRA - MarketBeat
A Look At Natera (NTRA) Valuation After Recent Share Price Weakness - simplywall.st
DAVENPORT & Co LLC Takes Position in Natera, Inc. - National Today
DAVENPORT & Co LLC Takes Position in Natera, Inc. $NTRA - marketbeat.com
Natera, Inc. $NTRA Shares Sold by Assenagon Asset Management S.A. - MarketBeat
Sentiment Review: What is the next catalyst for Natera IncCEO Change & Technical Entry and Exit Alerts - baoquankhu1.vn
Why Natera’s Stock Is Suddenly Sinking Hard - TipRanks
Elanco, Tandem Diabetes, Fortrea, Natera, and Myriad Genetics Shares Plummet, What You Need To Know - Yahoo Finance
Natera Inc (NTRA) Shares Down 4.14% on Mar 27 - GuruFocus
Vanguard disaggregates holdings; reports 0 shares for Natera (NTRA) - Stock Titan
Natera Inc Stock (NTRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.47%
0.53%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):